Cargando…

Dysregulated TRK Signalling is a Therapeutic Target in CYLD Defective Tumours

Individuals with germline mutations in the tumour suppressor gene CYLD are at high risk of developing disfiguring cutaneous appendageal tumours, the defining tumour being the highly organised cylindroma. Here, we analysed CYLD mutant tumour genomes by array comparative genomic hybridisation (aCGH) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajan, Neil, Elliott, Richard, Clewes, Oliver, Mackay, Alan, Reis-Filho, Jorge S., Burn, John, Langtry, James, Sieber-Blum, Maya, Lord, Christopher J., Ashworth, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175103/ https://www.ncbi.nlm.nih.gov/pubmed/21552290 http://dx.doi.org/10.1038/onc.2011.133

Ejemplares similares

Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial
por: Cranston, Amy, et al.
Publicado: (2017)

Overexpression of MYB drives proliferation of CYLD‐defective cylindroma cells
por: Rajan, Neil, et al.
Publicado: (2016)

Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical Trial
por: Danilenko, Marina, et al.
Publicado: (2018)

The cylindromatosis gene product, CYLD, interacts with MIB2 to regulate Notch signalling
por: Rajan, Neil, et al.
Publicado: (2014)

Tracking tumor kinetics in patients with germline CYLD mutations
por: Brown, Sarah, et al.
Publicado: (2018)

Inherited pulmonary cylindromas: extending the phenotype of CYLD mutation carriers
por: Brown, S.M., et al.
Publicado: (2018)

CYLD in health and disease
por: Marín-Rubio, José L., et al.
Publicado: (2023)

CYLD tumour supressor regulates ciligenesis
por: Eguether, T, et al.
Publicado: (2012)

CYLD dysregulation in pathogenesis of sporadic inclusion body myositis
por: Yamashita, Satoshi, et al.
Publicado: (2019)

Genetic Testing in CYLD Cutaneous Syndrome: An Update
por: Nagy, Nikoletta, et al.
Publicado: (2021)

SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling
por: Elliott, Paul R., et al.
Publicado: (2016)

Diverse presentations of cutaneous mosaicism occur in CYLD cutaneous syndrome and may result in parent-to-child transmission
por: Arefi, Majid, et al.
Publicado: (2019)

Neural Crest Stem Cell-specific Deletion of the Pygopus2 Gene Modulates Hair Follicle Development
por: Narytnyk, Alla, et al.
Publicado: (2013)

The tumour suppressor CYLD regulates the p53 DNA damage response
por: Fernández-Majada, Vanesa, et al.
Publicado: (2016)

SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes
por: Kupka, Sebastian, et al.
Publicado: (2016)

<i>CYLD</i> GeneticTesting for Brooke-Spiegler Syndrome, Familial Cylindromatosis and Multiple Familial Trichoepitheliomas
por: Dubois, Anna, et al.
Publicado: (2015)

CYLD and SUMO in neuroblastoma therapy
por: Masoumi, Katarzyna Chmielarska, et al.
Publicado: (2016)

NLK Is a Novel Therapeutic Target for PTEN Deficient Tumour Cells
por: Mendes-Pereira, Ana M., et al.
Publicado: (2012)

p63 and smooth muscle actin expression in low‐grade spiradenocarcinomas in a case of CYLD cutaneous syndrome
por: Hoyle, Aoisha, et al.
Publicado: (2018)

Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2
por: Martin, Sarah A, et al.
Publicado: (2009)

Epidermal Neural Crest Stem Cell (EPI-NCSC)—Mediated Recovery of Sensory Function in a Mouse Model of Spinal Cord Injury
por: Hu, Yao Fei, et al.
Publicado: (2010)

A novel large deletion of the CYLD gene causes CYLD cutaneous syndrome in a Chinese family
por: Zhu, Ruizheng, et al.
Publicado: (2020)

Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome
por: Davies, Helen R., et al.
Publicado: (2019)

Human Epidermal Neural Crest Stem Cells (hEPI-NCSC)—Characterization and Directed Differentiation into Osteocytes and Melanocytes
por: Clewes, Oliver, et al.
Publicado: (2011)

Differentiation of Human Epidermal Neural Crest Stem Cells (hEPI-NCSC) into Virtually Homogenous Populations of Dopaminergic Neurons
por: Narytnyk, Alla, et al.
Publicado: (2014)

Infiltrative Recurrent Eccrine Spiradenoma of the Anterior Neck Treated Using Mohs Micrographic Surgery
por: Rahim, Rajib R, et al.
Publicado: (2013)

UVB radiation represses CYLD expression in melanocytes
por: Kuphal, Silke, et al.
Publicado: (2017)

The cylindromatosis (CYLD) gene and head and neck tumorigenesis
por: Verhoeft, Krista Roberta, et al.
Publicado: (2016)

Gynaecological cylindroma in association with CYLD gene mutation
por: Khoury, Emma, et al.
Publicado: (2022)

Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation
por: Erol, Adnan
Publicado: (2022)

An RNA interference screen for identifying downstream effectors of the p53 and pRB tumour suppressor pathways involved in senescence
por: Rovillain, Emilie, et al.
Publicado: (2011)

Regulation of CYLD activity and specificity by phosphorylation and ubiquitin-binding CAP-Gly domains
por: Elliott, Paul R., et al.
Publicado: (2021)

Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer
por: Masoumi, K. C., et al.
Publicado: (2011)

CASPASE 8 inhibits programmed necrosis by processing CYLD
por: O’Donnell, Marie Anne, et al.
Publicado: (2011)

IKK-mediated CYLD phosphorylation and cellular redox activity
por: Erol, Adnan
Publicado: (2022)

Biological insights and novel biomarker discovery through deep learning approaches in breast cancer histopathology
por: Mandair, Divneet, et al.
Publicado: (2023)

The Tumour Suppressor CYLD Is Required for Clathrin-Mediated Endocytosis of EGFR and Cetuximab-Induced Apoptosis in Head and Neck Squamous Cell Carcinoma
por: Liu, Rin, et al.
Publicado: (2021)

CYLD regulates keratinocyte differentiation and skin cancer progression in humans
por: Alameda, J P, et al.
Publicado: (2011)

Mutual regulation between deubiquitinase CYLD and retroviral oncoprotein Tax
por: Wu, Xuefeng, et al.
Publicado: (2011)

Expression of CYLD and NF-κB in Human Cholesteatoma Epithelium
por: Byun, Jae Yong, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_vtlqn11jhml2h9n7gp1l2iu82l